Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

Phillip M. Devlin, MD, FACR

  • Chief, Division of Brachytherapy
  • Institute Physician
  • Associate Professor of Radiation Oncology, Harvard Medical School

Office Phone

  • 617-732-7936

Appointment Phone

  • 617-732-7936

Fax

  • 617-394-2669

General

Treatment Centers

Discipline

Clinical Interests

Brachytherapy for all sites, Brachytherapy training, Cutaneous oncology, Image-guided brachytherapy

Background

Board Certifications

  • Radiation Oncology

Fellowship

  • Memorial Sloan Kettering Cancer Center, Brachytherapy, 1996

Residency

  • Georgetown University Medical Center, Surgery
  • University of Pennsylvania School of Medicine, Radiation Oncology, 1995

Internships

  • Georgetown University Hospital, General Surgery, 1992

Medical School

  • University of Virginia School of Medicine, 1991

Biography

Phillip Devlin, MD, FACR is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center.  He earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.  Dr. Devlin joined the staff of Dana-Farber in 1997. In addition to lecturing extensively both nationally and internationally, Dr. Devlin established and directs the Harvard Medical School Annual Brachytherapy Review Course, has more than 50 published manuscripts and book chapters and is editor of the Lippincott, Williams and Wilkins’ text, Brachytherapy: Applications and Techniques.  Dr. Devlin is currently on the Executive Committees of both the American Society for Radiation Oncology (ASTRO) and the Massachusetts Radiological Society.  In 2008 he was named a Fellow of the American College of Radiology (FACR), and he is currently leading two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project.

Research

Dr. Devlin studies genetic markers for oral cavity cancer.